Comparison of different criteria for the definition of insulin resistance and its relationship to metabolic risk in children and adolescents
2
조회
0
다운로드
7
인용
0
참고문헌
키워드
초록
Purpose: Childhood obesity frequently persists into adulthood and is associated with insulin resistance (IR) and increased long-term morbidity and mortality. We compared IR criteria concerning 'age-specific cutoff point' (ACOP) and ‘fixed cutoff point’ (FCOP) for the identification of IR and investigated their correlation with metabolic syndrome (MS). Methods: Data were acquired from the 5th Korea National Health and Nutrition Examination Survey (2010–2011). Participants ranged from 10 to 17 years of age and underwent fasting plasma glucose, insulin concentration, and lipid panel measurements. High fasting plasma insulin levels or increased homeostatic model assessment insulin resistance (HOMA-IR) were defined as IR. We analyzed MS and IR frequencies according to FCOP or ACOP. Results: Among 719 participants, 165 (22.9%) were overweight or obese based on their body mass index. We found no prevalence of MS in underweight/normal weight participants and 12.7% prevalence rate in overweight or obese participants. IR according to ACOP was more closely associated with MS than IR according to FCOP. No differences were found in predicting the frequency of MS using FCOP or ACOP in both fasting plasma insulin and HOMA-IR. Conclusion: The frequency of MS in participants with IR defined using ACOP and FCOP was similar. However, IR using ACOP was more closely associated with MS than IR using FCOP.
Abstract
Purpose: Childhood obesity frequently persists into adulthood and is associated with insulin resistance (IR) and increased long-term morbidity and mortality. We compared IR criteria concerning 'age-specific cutoff point' (ACOP) and ‘fixed cutoff point’ (FCOP) for the identification of IR and investigated their correlation with metabolic syndrome (MS). Methods: Data were acquired from the 5th Korea National Health and Nutrition Examination Survey (2010–2011). Participants ranged from 10 to 17 years of age and underwent fasting plasma glucose, insulin concentration, and lipid panel measurements. High fasting plasma insulin levels or increased homeostatic model assessment insulin resistance (HOMA-IR) were defined as IR. We analyzed MS and IR frequencies according to FCOP or ACOP. Results: Among 719 participants, 165 (22.9%) were overweight or obese based on their body mass index. We found no prevalence of MS in underweight/normal weight participants and 12.7% prevalence rate in overweight or obese participants. IR according to ACOP was more closely associated with MS than IR according to FCOP. No differences were found in predicting the frequency of MS using FCOP or ACOP in both fasting plasma insulin and HOMA-IR. Conclusion: The frequency of MS in participants with IR defined using ACOP and FCOP was similar. However, IR using ACOP was more closely associated with MS than IR using FCOP.
참고문헌 (39)
- Lim SS, "A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010", Lancet, 380, pp.2224~2260 (2012)
- Carlos Alberto Nogueira-de-Almeida, "Different Criteria for the Definition of Insulin Resistance and ItsRelation with Dyslipidemia in Overweight and Obese Childrenand Adolescents", Pediatric Gastroenterology, Hepatology & Nutrition, 21(1), pp.59~67 (2018), 대한소아소화기영양학회
- de Onis M, "Preventing childhood overweight and obesity", J Pediatr (Rio J), 91, pp.105~107 (2015)
- Kurtoglu S, "Insulin resistance in obese children and adolescents : HOMA-IR cut-off levels in the prepubertal and pubertal periods", J Clin Res Pediatr Endocrinol, 2, pp.100~106 (2010)
- Yi KH, "Prevalence of insulin resistance and cardiometabolic risk in Korean children and adolescents : a population-based study", Diabetes Res Clin Pract, 103, pp.106~113 (2014)
- Papoutsakis C, "Metabolic syndrome in a Mediterranean pediatric cohort:prevalence using International Diabetes Federationderived criteria and associations with adiponectin and leptin", Metabolism, 61, pp.140~145 (2012)
- Ford ES, "Prevalence of the metabolic syndrome among U.S. adolescents using the definition from the International Diabetes Federation", Diabetes Care, 31, pp.587~589 (2008)
- Schwandt P, "Ethnic disparities of the metabolic syndrome in population-based samples of german and Iranian adolescents", Metab Syndr Relat Disord, 8, pp.189~192 (2010)
- Chen F, "Association between childhood obesity and metabolic syndrome : evidence from a large sample of Chinese children and adolescents", PLoS One, 7, pp.e47380~ (2012)
- Levy-Marchal C, "Insulin resistance in children : consensus, perspective, and future directions", J Clin Endocrinol Metab, 95, pp.5189~5198 (2010)
- Tam CS, "Defining insulin resistance from hyperinsulinemic-euglycemic clamps", Diabetes Care, 35, pp.1605~1610 (2012)
- Keskin M, "Homeostasis model assessment is more reliable than the fasting glucose", insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents, 2005, pp.115, e500~e503
- Weiss R, "Obesity and the metabolic syndrome in children and adolescents", N Engl J Med, 350, pp.2362~2374 (2004)
- Mieldazis SF, "Hyperinsulinism assessment in a sample of prepubescent children", J Pediatr (Rio J), 86, pp.245~249 (2010)
- Almeida CA, "Determination of glycemia and insulinemia and the homeostasis model assessment (HOMA) in schoolchildren and adolescents with normal body mass index", J Pediatr (Rio J), 84, pp.136~140 (2008)
- Garcia Cuartero B, "The HOMA and QUICKI indexes, and insulin and C-peptide levels in healthy children. Cut off points to identify metabolic syndrome in healthy children", An Pediatr (Barc), 66, pp.481~490 (2007)
- Matthews DR, "Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man", Diabetologia, 28, pp.412~419 (1985)
- Stevens GA, "National, regional, and global trends in adult overweight and obesity prevalences", Popul Health Metr, 10, pp.22~ (2012)
- Ten S, "Insulin resistance syndrome in children", J Clin Endocrinol Metab, 89, pp.2526~2539 (2004)
- 김재현, "The 2017 Korean National Growth Charts for children and adolescents: development, improvement, and prospects", Clinical and Experimental Pediatrics, 61(5), pp.135~149 (2018), 대한소아청소년과학회
- Zimmet P, "The metabolic syndrome in children and adolescents-an IDF consensus report", Pediatr Diabetes, 8, pp.299~306 (2007)
- "Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents:summary report", Pediatrics, 128(Suppl 5), pp.S213~S256 (2011)
- "Highlights of the report of the expert panel on blood cholesterol levels in children and adolescents. National Cholesterol Education Program Expert Panel on Blood Cholesterol Levels in Children and Adolescents", Am Fam Physician, 45, pp.2127~2136 (1992)
- Li Z, "Hypertriglyceridemia is a practical biomarker of metabolic syndrome in individuals with abdominal obesity", Metab Syndr Relat Disord, 11, pp.87~91 (2013)
- Li J, "Prevalence of pediatric dyslipidemia : comparison of a population-based claims database to national surveys", Pharmacoepidemiol Drug Saf, 19, pp.1031~1040 (2010)
- Hashemipour M, "Anthropometric indices associated with dyslipidemia in obese children and adolescents : a retrospective study in isfahan", ARYA Atheroscler, 7, pp.31~39 (2011)
- Elmaoğulları S, "Prevalence of dyslipidemia and associated factors in obese children and adolescents", J Clin Res Pediatr Endocrinol, 7, pp.228~234 (2015)
- Korsten-Reck U, "Frequency of secondary dyslipidemia in obese children", Vascular Health Risk Managem, 4, pp.1089~1094 (2008)
- Madeira IR, "The role of metabolic syndrome components and adipokines in insulin resistance in prepubertal children", J Pediatr Endocrinol Metab, 24, pp.289~295 (2011)
- Tester J, "Gender differences in prediabetes and insulin resistance among 1356 obese children in Northern California", Diabetes Metab Syndr, 7, pp.161~165 (2013)
- Juarez-Lopez C, "Insulin resistance and its association with the components of the metabolic syndrome among obese children and adolescents", BMC Public Health, 10, pp.318~ (2010)
- Lee JM, "Prevalence and determinants of insulin resistance among U. S. adolescents : a population-based study", Diabetes Care, 29, pp.2427~2432 (2006)
- Pulungan AB, "Prevalence of insulin resistance in obese adolescents", Paediatr Indones, 53, pp.167~172 (2013)
- Gobato AO, "Metabolic syndrome and insulin resistance in obese adolescents", Rev Paul Pediatr, 32, pp.55~62 (2014)
- Kim K, "Association of muscle mass and fat mass with insulin resistance and the prevalence of metabolic syndrome in Korean adults: a cross-sectional study", Sci Rep, 8, pp.2703~ (2018)
- Trirogoff ML, "Body mass index and fat mass are the primary correlates of insulin resistance in nondiabetic stage 3-4 chronic kidney disease patients", Am J Clin Nutr, 86, pp.1642~1648 (2007)
- Fung J, "Hyperinsulinemia and insulin resistance : scope of the problem", J Insulin Resist, 1, pp.1~6 (2016)
- Lunger F, "Accurate screening for insulin resistance in PCOS women using fasting insulin concentrations", Gynecol Endocrinol, 29, pp.541~544 (2013)
- Ghasemi A, "Cut-off points of homeostasis model assessment of insulin resistance, beta-cell function, and fasting serum insulin to identify future type 2diabetes: Tehran Lipid and Glucose Study", Acta Diabetol, 52, pp.905~915 (2015)